glydo (lidocaine hydrochloride) NDC 25021-673

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-673Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0673Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-673-76	25021067376	10 SYRINGE in 1 CARTON (25021-673-76) / 6 mL in 1 SYRINGEMarketed from Sep 15, 2014
25021-673-77	25021067377	10 SYRINGE in 1 CARTON (25021-673-77) / 11 mL in 1 SYRINGEMarketed from Sep 15, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): glydo
Generic name (nonproprietary): lidocaine hydrochloride
Active ingredients: Lidocaine hydrochloride anhydrous — 20 mg/mL
Dosage form: Jelly
Route: Topical
Labeler: Sagent Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201094
Marketing start: Sep 15, 2014
Listing expires: Dec 31, 2027
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 25021-673_17e6ad03-b5bc-4930-8db5-e787ef954448SPL ID 17e6ad03-b5bc-4930-8db5-e787ef954448SPL set ID 65760723-75cd-472c-96e1-7d05f95b4686RxCUI 1011852, 1549447UNII EC2CNF7XFP
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N425021067376 followed by a unit qualifier and the quantity

Package 25021-0673-76. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 4, 2026.

Indications (excerpt from the label)

GLYDO (lidocaine HCl jelly) 2% is an amide local anesthetic indicated: for prevention and control of pain in procedures involving the male and female urethra for topical treatment of painful urethritis as an anesthetic lubricant for oral and nasal endotracheal intubation GLYDO (lidocaine HCl jelly) 2% contains lidocaine, an amide local anesthetic, and is indicated in adult patients: for prevention and control of pain in procedures involving the male and female urethra ( 1 ) for topical treatment of painful urethritis ( 1 ) as an anesthetic lubricant for oral and nasal endotracheal intubation ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 201094

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201094
Product	Strength	Form · route	Labeler	Product NDC
GLYDO- lidocaine hydrochloride jelly	Lidocaine hydrochloride anhydrous 20 mg/mL	JellyTopical	HF Acquisition Co. LLC, DBA HealthFirst	51662-1652